The 12p13.33/RAD52 Locus and Genetic Susceptibility to Squamous Cell Cancers of Upper Aerodigestive Tract

Carregando...
Imagem de Miniatura
Citações na Scopus
10
Tipo de produção
article
Data de publicação
2015
Título da Revista
ISSN da Revista
Título do Volume
Editora
PUBLIC LIBRARY SCIENCE
Autores
DELAHAYE-SOURDEIX, Manon
OLIVER, Javier
TIMOFEEVA, Maria N.
GABORIEAU, Valerie
JOHANSSON, Mattias
CHABRIER, Amelie
WOZNIAK, Magdalena B.
BRENNER, Darren R.
VALLEE, Maxime P.
ANANTHARAMAN, Devasena
Citação
PLOS ONE, v.10, n.3, article ID e0117639, 12p, 2015
Projetos de Pesquisa
Unidades Organizacionais
Fascículo
Resumo
Genetic variants located within the 12p13.33/RAD52 locus have been associated with lung squamous cell carcinoma (LUSC). Here, within 5,947 UADT cancers and 7,789 controls from 9 different studies, we found rs10849605, a common intronic variant in RAD52, to be also associated with upper aerodigestive tract (UADT) squamous cell carcinoma cases (OR = 1.09, 95% CI: 1.04-1.15, p = 6x10(-4)). We additionally identified rs10849605 as a RAD52 cis-eQTL inUADT(p = 1x10(-3)) and LUSC (p = 9x10(-4)) tumours, with the UADT/LUSC risk allele correlated with increased RAD52 expression levels. The 12p13.33 locus, encompassing rs10849605/RAD52, was identified as a significant somatic focal copy number amplification in UADT(n = 374, q-value = 0.075) and LUSC (n = 464, q-value = 0.007) tumors and correlated with higher RAD52 tumor expression levels (p = 6x10(-48) and p = 3x10(-29) in UADT and LUSC, respectively). In combination, these results implicate increased RAD52 expression in both genetic susceptibility and tumorigenesis of UADT and LUSC tumors.
Palavras-chave
Referências
  1. Adzhubei IA, 2010, NAT METHODS, V7, P248, DOI 10.1038/nmeth0410-248
  2. Anantharaman D, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088240
  3. Baumann P, 1998, TRENDS BIOCHEM SCI, V23, P247, DOI 10.1016/S0968-0004(98)01232-8
  4. Beroukhim R, 2007, P NATL ACAD SCI USA, V104, P20007, DOI 10.1073/pnas.0710052104
  5. Cramer-Morales K, 2013, BLOOD, V122, P1293, DOI 10.1182/blood-2013-05-501072
  6. Delahaye-Sourdeix M, 2015, J NATL CANC IN PRESS
  7. Du P, 2010, BMC BIOINFORMATICS, V11, P587, DOI 10.1186/1471-2105-11-587
  8. Feng ZH, 2011, P NATL ACAD SCI USA, V108, P686, DOI 10.1073/pnas.1010959107
  9. Ferlay J, 2010, INT J CANCER, V127, P2893, DOI 10.1002/ijc.25516
  10. Flicek P, 2013, NUCLEIC ACIDS RES, V41, pD48, DOI 10.1093/nar/gks1236
  11. Hoeijmakers JHJ, 2001, NATURE, V411, P366, DOI 10.1038/35077232
  12. Li QY, 2013, CELL, V152, P633, DOI 10.1016/j.cell.2012.12.034
  13. Liu J, 2011, P NATL ACAD SCI USA, V108, P441, DOI 10.1073/pnas.1016614108
  14. Lok BH, 2012, CLIN CANCER RES, V18, P6400, DOI 10.1158/1078-0432.CCR-11-3150
  15. Lok BH, 2013, ONCOGENE, V32, P3552, DOI 10.1038/onc.2012.391
  16. McKay JD, 2011, PLOS GENET, V7, DOI [10.1371/journal.pgen.1001333, DOI 10.1371/JOURNAL.PGEN.1001333]
  17. Mermel CH, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-4-r41
  18. Mortazavi A, 2008, NAT METHODS, V5, P621, DOI 10.1038/nmeth.1226
  19. Negri E, 2009, INT J CANCER, V124, P394, DOI 10.1002/ijc.23848
  20. Ng PC, 2003, NUCLEIC ACIDS RES, V31, P3812, DOI 10.1093/nar/gkg509
  21. Oze I, 2010, CANCER SCI, V101, P1875, DOI 10.1111/j.1349-7006.2010.01599.x
  22. Portela A, 2010, NAT BIOTECHNOL, V28, P1057, DOI 10.1038/nbt.1685
  23. Price AL, 2006, NAT GENET, V38, P904, DOI 10.1038/ng1847
  24. Pritchard JK, 2000, GENETICS, V155, P945
  25. Robinson MD, 2010, BIOINFORMATICS, V26, P139, DOI 10.1093/bioinformatics/btp616
  26. Robinson MD, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-3-r25
  27. Scully C, 2000, ORAL ONCOL, V36, P256, DOI 10.1016/S1368-8375(00)00007-5
  28. Shi JX, 2012, CANCER DISCOV, V2, P131, DOI 10.1158/2159-8290.CD-11-0246
  29. Smyth G. K., 2005, BIOINFORMATICS COMPU, P397, DOI 10.1007/0-387-29362-0_23
  30. Stewart BW, 2003, WORLD CANC REPORT
  31. Stranger BE, 2007, SCIENCE, V315, P848, DOI 10.1126/science.1136678
  32. Sung P, 2006, NAT REV MOL CELL BIO, V7, P739, DOI 10.1038/nrm2008
  33. Symington LS, 2002, MICROBIOL MOL BIOL R, V66, P630, DOI 10.1128/MMBR.66.4.630-670.2002
  34. Thacker J, 1999, BIOCHIMIE, V81, P77, DOI 10.1016/S0300-9084(99)80041-8
  35. Frazer KA, 2007, NATURE, V449, P851, DOI 10.1038/nature06258
  36. Timofeeva MN, 2012, HUM MOL GENET, V21, P4980, DOI 10.1093/hmg/dds334
  37. Wang YF, 2014, NAT GENET, V46, P736, DOI 10.1038/ng.3002
  38. Yan W, 2011, AM J CANCER RES, V1, P275
  39. Yu K, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002551